Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Retinal Neoplasms 1Oropharyngeal Neoplasms 1Nonsquamous Non-small Cell Lung Cancer 1Melanoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 14Radiotherapy, Intensity-Modulated 12pembrolizumab 7Radiotherapy 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Platinum 6Carboplatin 6Radiation 51,2-diaminocyclohexaneplatinum II citrate 5Taxes 3Surveys and Questionnaires 3Paclitaxel 3Nivolumab 3Fluorodeoxyglucose F18 3Biopsy 3durvalumab 2Drug Therapy 2prednylidene 1peposertib 1niraparib 1exifone 1entinostat 1dostarlimab 1deltacortene 1dehydroftorafur 1cemiplimab 1bintrafusp alfa protein, human 1atezolizumab 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Oropharyngeal Neoplasms × Platinum Compounds × Clear all
NCT06234748 2026-05-18

ARTHOUSE

University of Michigan Rogel Cancer Center

Phase 2 Active not recruiting
19 enrolled
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡